Pleomorphic Giant Cell Carcinoma of the Prostate Treated With Lutetium‐177 PSMA
Case Reports in Urology · 2026-01 · 2026 (1)
DOI: 10.1155/criu/1304419 ↗Kurz gefasst
Fachartikel in der Zeitschrift Case Reports in Urology, online erschienen am 05.08.2026. Verfasst von John Y Kwon und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA, mayo.edu. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pleomorphic giant cell carcinoma (PGCC) of the prostate is an extremely rare and aggressive malignancy with limited treatment options. We present a case report of metastatic PGCC patients treated with 177 Lu‐PSMA‐617 radioligand therapy (Pluvicto) after progression on standard therapies. Both patients had PSMA‐avid tumors on imaging. Molecular profiling revealed mutations in hallmark tumor suppressors including TP53, RB1, and PTEN. Both patients initially experienced partial radiographic response, in which one patient achieved stable disease for 9 months posttherapy. These findings suggest that PSMA‐radioligand therapy may be a reasonable treatment for PGCC patients, but underscore the need for additional therapeutic options.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA, mayo.edu.
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA, mayo.edu.
- Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA, mayo.edu.
- Department of Urology, Mayo Clinic, Rochester, Minnesota, USA, mayo.edu.
- Department of Internal Medicine, Division of Oncology, Mayo Clinic, Phoenix, Arizona, USA, mayo.edu.
- Department of Radiology, Division of Nuclear Medicine, Mayo Clinic, Rochester, Minnesota, USA, mayo.edu.
ORCID-Profile: John Y Kwon, John C Cheville, Miguel Muniz-Rincon, Irbaz Riaz, Dan S Childs, Geoffrey Johnson, Oliver Sartor, Lance C Pagliaro, Jacob J Orme
Zitieren
APA
Kwon, J. Y., Cheville, J. C., Muniz-Rincon, M., Ahmed, M. E., Kwon, E. D., Riaz, I., Childs, D. S., Johnson, G., Sartor, O., Pagliaro, L. C., & Orme, J. J. (2026). Pleomorphic Giant Cell Carcinoma of the Prostate Treated With Lutetium‐177 PSMA. Case Reports in Urology, 2026(1). https://doi.org/10.1155/criu/1304419
Vancouver
Kwon JY, Cheville JC, Muniz-Rincon M, Ahmed ME, Kwon ED, Riaz I, et al. Pleomorphic Giant Cell Carcinoma of the Prostate Treated With Lutetium‐177 PSMA. Case Reports in Urology. 2026;2026(1). doi:10.1155/criu/1304419
BibTeX
@article{Kwon2026,
author = {Kwon, John Y and Cheville, John C and Muniz-Rincon, Miguel and Ahmed, Mohamed E and Kwon, Eugene D and Riaz, Irbaz and Childs, Dan S and Johnson, Geoffrey and Sartor, Oliver and Pagliaro, Lance C and Orme, Jacob J},
title = {Pleomorphic Giant Cell Carcinoma of the Prostate Treated With Lutetium‐177 PSMA},
journal = {Case Reports in Urology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/criu/1304419}
}
EUVIMED